Larvol Delta - Novo-Holdings-coleads-1814-million-Series-D-nancing-in-Alentis-Therapeutics-to-advance-groundbreaking-antibodydrug-conjugates-ADCs-for-solid-tumours

ALE.P02 - Alentis Therap

ALE.P03 - Alentis Therap

https://www.prnewswire.com/news-releases/novo-holdings-co-leads-181-4-million-series-d-financing-in-alentis-therapeutics-to-advance-groundbreaking-antibody-drug-conjugates-adcs-for-solid-tumours-302301683.html

Nov 12, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next